Aegerion Pharmaceuticals, Inc. 4
4 · Aegerion Pharmaceuticals, Inc. · Filed Jan 5, 2015
Insider Transaction Report
Form 4
Sumeray Mark
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2014-12-31+65,000→ 65,000 totalExercise: $15.95Exp: 2022-01-23→ Common Stock (65,000 underlying)
Footnotes (1)
- [F1]On January 23, 2012, the reporting person was granted an option to purchase 65,000 shares of common stock, subject to time and performance vesting criteria. The time and performance criteria have been met with respect to this award.